# Boston Scientific to acquire Baylis Medical for $1.75B

Boston Scientific has entered a definitive agreement to acquire Baylis Medical Company Inc. for $1.75 billion upfront, adding transseptal platforms and left heart access products to its electrophysiology and structural heart portfolios.

- Type: Acquisition
- Announced: 2021-10-06
- Where: Marlborough, Massachusetts, United States
- Value: $1.75B
- Status: announced
- Products: radiofrequency transseptal platforms, guidewires, sheaths, dilators
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Baylis Medical Company](https://endata.com/companies/29541.md) (target)

## Sources

- [news.bostonscientific.com](https://news.bostonscientific.com/2021-10-06-Boston-Scientific-Announces-Agreement-to-Acquire-Baylis-Medical-Company-Inc), 2021-10-06: "The acquisition will expand the Boston Scientific electrophysiology and structural heart product portfolios to include the radiofrequency (RF) NRG ® and VersaCross ® Transseptal Platforms as well as a family of guidewires, sheaths and dilators used to support left heart access."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.